|The prevalence of pituitary adenomas: a systematic review|
S Ezzat, SL Asa, WT Couldwell, CE Barr, WE Dodge, ML Vance, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
|Thyroid incidentalomas: prevalence by palpation and ultrasonography|
S Ezzat, DA Sarti, DR Cain, GD Braunstein
Archives of internal medicine 154 (16), 1838-1840, 1994
|Pathogenetic mechanisms in thyroid follicular-cell neoplasia|
T Kondo, S Ezzat, SL Asa
Nature Reviews Cancer 6 (4), 292-306, 2006
|Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting|
NF Gonzalez-Cadavid, WE Taylor, K Yarasheski, I Sinha-Hikim, K Ma, ...
Proceedings of the National Academy of Sciences 95 (25), 14938-14943, 1998
|The cytogenesis and pathogenesis of pituitary adenomas|
SL Asa, S Ezzat
Endocrine reviews 19 (6), 798-827, 1998
|The pathogenesis of pituitary tumours|
SL Asa, S Ezzat
Nature Reviews Cancer 2 (11), 836-849, 2002
|Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings|
E Thodou, SL Asa, G Kontogeorgos, K Kovacs, E Horvath, S Ezzat
The Journal of Clinical Endocrinology & Metabolism 80 (8), 2302-2311, 1995
|Immunohistochemical diagnosis of papillary thyroid carcinoma|
CC Cheung, S Ezzat, JL Freeman, IB Rosen, SL Asa
Modern pathology 14 (4), 338-342, 2001
|American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update|
L Katznelson, JLD Atkinson, DM Cook, SZ Ezzat, AH Hamrahian, ...
Endocrine practice 17, 1-44, 2011
|Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia|
SL Sugg, S Ezzat, IB Rosen, JL Freeman, SL Asa
The Journal of Clinical Endocrinology & Metabolism 83 (11), 4116-4122, 1998
|Octreotide treatment of acromegaly: a randomized, multicenter study|
S Ezzat, PJ Snyder, WF Young, LD Boyajy, C Newman, A Klibanski, ...
Annals of Internal Medicine 117 (9), 711-718, 1992
|Insulin and related factors in premenopausal breast cancer risk|
ME Del Giudice, IG Fantus, S Ezzat, G McKeown-Eyssen, D Page, ...
Breast cancer research and treatment 47 (2), 111-120, 1998
|Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis|
AM Sawka, L Thabane, L Parlea, I Ibrahim-Zada, RW Tsang, JD Brierley, ...
Thyroid 19 (5), 451-457, 2009
|Diagnosis and management of hyperprolactinemia|
O Serri, CL Chik, E Ur, S Ezzat
Cmaj 169 (6), 575-581, 2003
|Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cyst, and arachnoid cyst|
JL Shin, SL Asa, LJ Woodhouse, HS Smyth, S Ezzat
The Journal of Clinical Endocrinology & Metabolism 84 (11), 3972-3982, 1999
|Acromegaly. Clinical and biochemical features in 500 patients.|
S Ezzat, MJ Forster, P Berchtold, DA Redelmeier, V Boerlin, AG Harris
Medicine 73 (5), 233-240, 1994
|The pathogenesis of pituitary tumors|
SL Asa, S Ezzat
Annual Review of Pathology: Mechanisms of Disease 4, 97-126, 2009
|Mutations of the MEN1 tumor suppressor gene in pituitary tumors|
Z Zhuang, SZ Ezzat, AO Vortmeyer, R Weil, EH Oldfield, WS Park, S Pack, ...
Cancer research 57 (24), 5446-5451, 1997
|Myostatin and insulin-like growth factor-I and-II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight|
R Lalani, S Bhasin, F Byhower, R Tarnuzzer, M Grant, R Shen, S Asa, ...
Journal of Endocrinology 167 (3), 417-428, 2000
|The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults|
LJ Woodhouse, A Mukherjee, SM Shalet, S Ezzat
Endocrine reviews 27 (3), 287-317, 2006